The DOI matches its Crossref record; 179 of the 179 references it cites were found in a registry or an index.
‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?*
Abstract
Associations between modifiable exposures and disease seen in observational epidemiology are sometimes confounded and thus misleading, despite our best efforts to improve the design and analysis of studies. Mendelian randomization—the random assortment of genes from parents to offspring that occurs during gamete formation and conception—provides one method for assessing the causal nature of some environmental exposures. The association between a disease and a polymorphism that mimics the biological link between a proposed exposure and disease is not generally susceptible to the reverse causation or confounding that may distort interpretations of conventional observational studies. Several examples where the phenotypic effects of polymorphisms are well documented provide encouraging evidence of the explanatory power of Mendelian randomization and are described. The limitations of the approach include confounding by polymorphisms in linkage disequilibrium with the polymorphism under study, that polymorphisms may have several phenotypic effects associated with disease, the lack of suitable polymorphisms for studying modifiable exposures of interest, and canalization—the buffering of the effects of genetic variation during development. Nevertheless, Mendelian randomization provides new opportunities to test causality and demonstrates how investment in the human genome project may contribute to understanding and preventing the adverse effects on human health of modifiable exposures. Genetic epidemiology—the theme of this issue of the International Journal of Epidemiology—is seen by many to be the only future for epidemiology, perhaps reflecting a growing awareness of the limitations of observational epidemiology1 (Box 1). Genetic epidemiology is concerned with understanding heritable aspects of disease risk, individual susceptibility to disease, and ultimately with contributing to a comprehensive molecular understanding of pathogenesis. The massive investment and expansion of human genetics, if it is to return value for the common good, must be integrated into public health functions. The human genome epidemiology network (HuGE Net—http://www.cdc.gov/genetics/huge.htm) has been established to promote the use of genetic knowledge—in terms of genetic tests and services—for disease prevention and health promotion.2,3 A broad taxonomy of human genome studies of public health relevance has been developed4 (Box 2). In this issue of the IJE, we publish a paper by Miguel Porta,5 who highlights the need for a more rational approach to genetic testing, given the likely low penetrance of many genes associated with cancers,6 likening the role of the genome to a jazz score that is interpreted and developed through experience and context—and is seldom predictable. Such insights may well temper enthusiasm for genetic testing in populations. However, in parallel to the approaches advocated by HuGE, genetic epidemiology can lead to a more robust understanding of environmental determinants of disease (e.g. dietary factors, occupational exposures, and health-related behaviours) relevant to whole populations (and not simply to genetically susceptible sub-populations).7–10 This approach has recently been referred to as ‘Mendelian randomization’.11–15 Here we begin by briefly reviewing reasons for current concerns about aetiological findings generated by conventional observational epidemiology and then we outline the potential contribution (and limitations) of Mendelian randomization. ‘Epidemiology set to get fast-track treatment’ ‘A consortium of leading European research centres and pharmaceutical companies will this week announce a plan to transform epidemiology by combining it with the new techniques of high-throughput biology. They plan to create a new field of study—genomic epidemiology—by using screening technologies derived from the human genome project … We think it is important to expand classical epidemiology and genetic epidemiology to take it to this high-throughput mode, says Esper Boel, vice-president of biotechnology research at Novo Nordisk. We want to use post-genomic technologies to create a new clinical science, to turn functional genomics into real clinical chemistry.’ From: Butler D. Epidemiology set to get fast-track treatment. Nature 2001;414:139. Reprinted with permission. Surveillance Population frequency of gene variants predisposing to specific diseases Population frequency of morbidity and mortality from such diseases Population frequency and effects of environmental factors known to interact with gene variants Economic costs of genetic components of diseases Coverage, access, and uptake of genetic tests and services Aetiology Magnitude of disease risk associated with gene variants in different populations Contribution of gene variants to the overall level of disease in different populations Magnitude of disease risk associated with gene–gene and gene–environment interactions in different populations Heal
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The essence of an MR design is that the association between a genetic variant (G) and an outcome (Y) can be used to test whether and by how much the exposure of interest (X) influences the outcome, provided that the genetic variant is associated with the exposure of interest and has no other source of association with the outcome.1,9”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“When initially presented, it was concluded that “[MR] offers a more robust approach to understanding the effect of some modifiable exposures on health outcomes than does much conventional observational epidemiology”1 and that where possible, RCTs should follow to establish the effects of interventions. This conclusion remains unchanged, although moving towards formal triangulation of all pertinent”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Canalization can occur when polymorphic phenotypes expressed during fetal development lead to the development of compensating pathways to mitigate the effects of that expression. 1,178,179”
From Mendelian randomization (2022) · cites this paper as [1]
In the citing paper
“Estimating effect sizes through the instrumental variable approach imposes a fourth assumption, usually homogeneity of effects of the exposure on the outcome.16 58 59 60”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Most MR studies rely on three core IV assumptions (relevance, independence, and exclusion restriction; fig 1, box 3) to carry out testing for causal effects of the exposure on the outcome.16”
From Strengthening the Reporting of Observational Studies in Epidemiology using Mendelian Randomisation (STROBE-MR): explanation and elaboration. (2021) · cites this paper as [16]
In the citing paper
“Similarly, violation of the ‘exclusion restriction criteria’33–37 could bias causal estimates in IV analyses when used to test effects of intermediates in RCTs or when used in observational data (including MR)”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“but may be confounded by population stratification.33,34”
From Triangulation in aetiological epidemiology (2017) · cites this paper as [34]
In the citing paper
“Human genetics can provide compelling evidence of causation through approaches such as Mendelian randomization (MR).”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Performed well, such studies called Mendelian randomization (MR) analyses, can provide rigorous evidence of causation 9,10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“We can exploit the properties of the human genome (specifically, the random segregation of alleles and their non-modifiable nature) to make causal inferences about the relationships between risk factors and disease 10 .”
From Integrating genomics with biomarkers and therapeutic targets to invigorate cardiovascular drug development (2021) · cites this paper as [10]
In the citing paper
“Mendelian randomization uses genetic variants, assumed to be instrumental variables for a particular exposure, to estimate the causal effect of that exposure on an outcome.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
In the citing paper
“If the instrumental variable criteria are satisfied, the resulting estimator is consistent even in the presence of unmeasured confounding and reverse causation.”
From Network Mendelian randomization: using genetic variants as instrumental variables to investigate mediation in causal pathways. (2015) · cites this paper as [1]
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Spielman, R. S., McGinnis, R. E., & Ewens, W. J. (1993) · PubMed · Cited by 3,679
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638
Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
(1991) · The Lancet · doi:10.1016/0140-6736(91)90133-a · Cited by 3,472
CANALIZATION OF DEVELOPMENT AND THE INHERITANCE OF ACQUIRED CHARACTERS
WADDINGTON, C. H. (1942) · Nature · doi:10.1038/150563a0 · Cited by 3,255
Flagged first, then by citations
Research works printed but not linked: 3
- Skrabanek P. False Premises, False Promises. Whithorn: Tarragon Press, 2000.
- http://www.ncbi.nlm.nih.gov/Omim (accessed 12 Dec 2002).
- Heart Protection Study Collaborative Group. MRC/BHF heart protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals. Lancet2002;360:7–22. · DOI · Paper page
Cited by
Sorted by citations
Items 601–700 of 1,037
Sattar, N., McConnachie, A., O’Reilly, D., Upton, M. N., Greer, I. A., Smith, G. D., & Watt, G. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000118277.41584.63 · Cited by 99
Effect of alcohol on risk of coronary heart disease and stroke: causality, bias, or a bit of both?
Emberson, J. R., & Bennett, D. A. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.239 · Cited by 99
Bias in Mendelian randomization due to assortative mating
Hartwig, F. P., Davies, N. M., & Davey Smith, G. (2018) · Genetic Epidemiology · doi:10.1002/gepi.22138 · Cited by 99
Cai, J., He, L., Wang, H., Rong, X., Chen, M., Shen, Q., Li, X., Li, M., & Peng, Y. (2021) · Addiction · doi:10.1111/add.15767 · Cited by 99
Genetics of common cerebral small vessel disease
Bordes, C., Sargurupremraj, M., Mishra, A., & Debette, S. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-021-00592-8 · Cited by 108
Diabetes and cancer risk: A Mendelian randomization study
Goto, A., Yamaji, T., Sawada, N., Momozawa, Y., Kamatani, Y., Kubo, M., Shimazu, T., Inoue, M., Noda, M., Tsugane, S., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32310 · Cited by 100
Ye, Z., Kappelmann, N., Moser, S., Smith, G. D., Burgess, S., Jones, P. B., & Khandaker, G. M. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100992 · Cited by 105
Alcohol consumption and telomere length: Mendelian randomization clarifies alcohol’s effects
Topiwala, A., Taschler, B., Ebmeier, K. P., Smith, S. M., Zhou, H., Levey, D. F., Codd, V., Samani, N. J., Gelernter, J. E., Nichols, T. E., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01690-9 · Cited by 97
Lawlor, D. A., Nordestgaard, B. G., Benn, M., Zuccolo, L., Tybjærg‐Hansen, A., & Smith, G. D. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht081 · Cited by 96
Fetal Alcohol Exposure and IQ at Age 8: Evidence from a Population-Based Birth-Cohort Study
Lewis, S. J., Zuccolo, L., Smith, G. D., Macleod, J., Rodrı́guez, S., Draper, E. S., Barrow, M., Alati, R., Sayal, K. S., Ring, S. M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049407 · Cited by 104
Yu, K., Chen, X., Guo, J., Wang, S., Huang, X., Guo, Y., Dong, S., & Yang, T. (2023) · BMC Medicine · doi:10.1186/s12916-023-02982-9 · Cited by 95
Seifart, C., Dempfle, A., Plagens, A., Seifart, U., Clostermann, U., Müller, B., Vogelmeier, C. F., & von Wichert, P. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00343.x · Cited by 96
The emergence of epidemiology in the genomics age
Khoury, M. J. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh278 · Cited by 97
The role of longitudinal cohort studies in epigenetic epidemiology: challenges and opportunities
Ng, J. W. Y., Barrett, L. M., Wong, A., Kuh, D. J., Smith, G. D., & Relton, C. L. (2012) · Genome biology · doi:10.1186/gb-2012-13-6-246 · Cited by 97
Fisher, E., Stefan, N., Saar, K., Drogan, D., Schulze, M. B., Fritsche, A., Joost, H., Häring, H., Hübner, N., Boeing, H., et al. (2009) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.870410 · Cited by 97
Walker, V. M., Kehoe, P. G., Martin, R. M., & Davies, N. M. (2018) · doi:10.1101/486878 · Cited by 96
Integration of molecular pathology, epidemiology and social science for global precision medicine
Nishi, A., Milner, D. A., Giovannucci, E. L., Nishihara, R., Tan, A. S. L., Kawachi, I. I., & Ogino, S. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1115346 · Cited by 98
Clarifying questions about “risk factors”: predictors versus explanation
Schooling, C. M., & Jones, H. E. (2018) · Emerging Themes in Epidemiology · doi:10.1186/s12982-018-0080-z · Cited by 102
Greenstone, H., Wootton, R. E., Abdellaoui, A., Denys, D. A. J. P., Verweij, K. J. H., Munafo, M. R., & Treur, J. L. (2020) · Addiction · doi:10.1111/add.15142 · Cited by 99
Georgakis, M. K., & Gill, D. (2021) · Stroke · doi:10.1161/strokeaha.120.032617 · Cited by 99
Tools for assessing quality and risk of bias in Mendelian randomization studies: a systematic review
Spiga, F., Gibson, M., Dawson, S., Tilling, K. M., Smith, G. D., Munafo, M. R., & Higgins, J. P. T. (2022) · International Journal of Epidemiology · doi:10.1093/ije/dyac149 · Cited by 96
Researching Genetic Versus Nongenetic Determinants of Disease: A Comparison and Proposed Unification
Ioannidis, J. P. A., Loy, E. Y., Poulton, R., & Chia, K. S. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000247 · Cited by 95
Langdahl, B. L., Uitterlinden, A. G., Ralston, S. H., Trikalinos, T. A., Balcells, S., Brandi, M. L., Scollen, S., Lips, P. T. A. M., Lorenc, R., Obermayer-Pietsch, B. M., et al. (2007) · Bone · doi:10.1016/j.bone.2007.11.007 · Cited by 96
Using Multivariable Mendelian Randomization to Disentangle the Causal Effects of Lipid Fractions
Burgess, S., Freitag, D. F., Khan, H., Gorman, D. N., & Thompson, S. G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108891 · Cited by 95
DNA Methylation and BMI: Investigating Identified Methylation Sites at HIF3A in a Causal Framework
Richmond, R. C., Sharp, G. C., Ward, M. E., Fraser, A., Lyttleton, O., McArdle, W. L., Ring, S. M., Gaunt, T. R., Lawlor, D. A., Smith, G. D., et al. (2016) · Diabetes · doi:10.2337/db15-0996 · Cited by 97
Mulugeta, A., Zhou, A., King, C. E., & Hyppönen, E. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0486-1 · Cited by 90
Zeng, P., Wang, T., Zheng, J., & Zhou, X. (2019) · BMC Medicine · doi:10.1186/s12916-019-1448-9 · Cited by 97
Frikke-Schmidt, R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.06.005 · Cited by 94
Maalmi, H., Walter, V., Jansen, L., Boakye, D., Schöttker, B., Hoffmeister, M., & Brenner, H. (2018) · Nutrients · doi:10.3390/nu10070896 · Cited by 94
Genetic association between adiposity and gout: a Mendelian randomization study
Larsson, S. C., Burgess, S., & Michaëlsson, K. (2018) · Rheumatology · doi:10.1093/rheumatology/key229 · Cited by 97
Hamel, A. R., Yan, W., Rouhana, J. M., Monavarfeshani, A., Jiang, X., Mehta, P. A., Advani, J., Luo, Y., Liang, Q., Rajasundaram, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44380-y · Cited by 100
How Does Body Fat Influence Bone Mass in Childhood? A Mendelian Randomization Approach
Timpson, N. J., Sayers, A. E., Smith, G. D., & Tobias, J. H. (2008) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.081109 · Cited by 94
Does Elevated Plasma Fibrinogen Increase the Risk of Coronary Heart Disease?
Smith, G. D., Harbord, R. M., Milton, J., Ebrahim, S. B. J., & Sterne, J. A. C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000183937.65887.9c · Cited by 94
Self-citationMendelian Randomization Study of Body Mass Index and Colorectal Cancer Risk
Thrift, A. P., Gong, J., Peters, U., Chang-Claude, J. C., Rudolph, A., Slattery, M. L., Chan, A. T., Locke, A. E., Kahali, B., Justice, A. E., et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1309 · Cited by 97
Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study
Manousaki, D., Harroud, A., Mitchell, R. E., Ross, S. A., Forgetta, V., Timpson, N. J., Smith, G. D., Polychronakos, C., & Richards, J. B. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003536 · Cited by 93
Genetically predicted obesity and risk of deep vein thrombosis
Tan, J., Liu, N., Guo, T., Hu, S., & Hua, L. (2021) · Thrombosis Research · doi:10.1016/j.thromres.2021.08.026 · Cited by 94
Vergeer, M., Boekholdt, S. M., Sandhu, M. S., Ricketts, S. L., Wareham, N. J., Brown, M. J., Fairé, U. D., Leander, K., Gigante, B., Kavousi, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.912519 · Cited by 94
Ten simple rules for conducting a mendelian randomization study
Taliun, S. A. G., & Evans, D. M. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1009238 · Cited by 96
Morrison, A. E., Zaccardi, F., Khunti, K., & Davies, M. J. (2019) · Liver International · doi:10.1111/liv.13994 · Cited by 92
Genetics of human longevity within an eco-evolutionary nature-nurture framework
Giuliani, C., Garagnani, P., & Franceschi, C. (2018) · Circulation Research · doi:10.1161/circresaha.118.312562 · Cited by 92
Time to target uric acid to retard CKD progression
Kumagai, T., Ota, T., Tamura, Y., Chang, W., Shibata, S., & Uchida, S. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-016-1288-2 · Cited by 92
Taylor, A. E., Richmond, R. C., Palviainen, T., Loukola, A., Wootton, R. E., Kaprio, J. A., Relton, C. L., Smith, G. D., & Munafo, M. R. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy434 · Cited by 95
Evans, D. M., Moen, G.-H., Hwang, L., Lawlor, D. A., & Warrington, N. M. (2019) · International Journal of Epidemiology · doi:10.1093/ije/dyz019 · Cited by 94
Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors
Burgess, S., Butterworth, A. S., & Thompson, J. R. (2015) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.08.001 · Cited by 93
IL6 and CRPhaplotypes are associated with COPD risk and systemic inflammation: a case-control study
Yanbaeva, D. G., Dentener, M. A., Spruit, M. A., Houwing‐Duistermaat, J. J., Kotz, D., Passos, V. L., & Wouters, E. F. �. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-23 · Cited by 92
The vitamin D slant on allergy
Wjst, M. (2006) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2006.00456.x · Cited by 92
Herder, C., Klopp, N., Baumert, J., Müller‐Nurasyid, M., Khuseyinova, N., Meisinger, C., Martin, S., Illig, T., Köenig, W., & Thorand, B. (2007) · Diabetologia · doi:10.1007/s00125-007-0800-3 · Cited by 93
Silva, N. M. G. D., Freathy, R. M., Palmer, T., Donnelly, L. A., Luan, J., Gaunt, T. R., Langenberg, C., Weedon, M. N., Shields, B. M., Knight, B. A., et al. (2011) · Diabetes · doi:10.2337/db10-1317 · Cited by 91
Self-citationEvidence of a Causal Relationship Between Adiponectin Levels and Insulin Sensitivity
Gao, H., Fall, T., van Dam, R. M., Flyvbjerg, A., Zethelius, B., Ingelsson, E., & Hägg, S. (2012) · Diabetes · doi:10.2337/db12-0935 · Cited by 90
Zhang, X., Zhao, Q., Zhu, W. J., Liu, T., Xie, S.-H., Zhong, L.-X., Cai, Y., Li, X., Liang, M., Chen, W. L., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0968 · Cited by 89
Mendelian Randomization Studies of Coffee and Caffeine Consumption
Cornelis, M. C., & Munafo, M. R. (2018) · Nutrients · doi:10.3390/nu10101343 · Cited by 89
Mendelian randomization: causal inference leveraging genetic data
Chen, L. G., Tubbs, J. D., Liu, Z., Thach, T., & Sham, P. C. (2024) · Psychological Medicine · doi:10.1017/s0033291724000321 · Cited by 93
TNF‐α, TNF‐β, IL‐6, and IL‐10 Polymorphisms in Patients with Lung Cancer
Seifart, C., Plagens, A., Dempfle, A., Clostermann, U., Vogelmeier, C. F., von Wichert, P., & Seifart, U. (2005) · Disease Markers · doi:10.1155/2005/707131 · Cited by 91
Sanderson, S. C., Salanti, G., & Higgins, J. P. T. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm167 · Cited by 91
Evaluation of Genetic Markers as Instruments for Mendelian Randomization Studies on Vitamin D
Berry, D. J., Vimaleswaran, K. S., Whittaker, J. C., Hingorani, A. D., & Hyppönen, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037465 · Cited by 88
Gatto, N. M. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh306 · Cited by 91
Ross, S., D’Mello, M., Anand, S. S., Eikelboom, J., CARDIoGRAMplusC4D Consortium*, Stewart, A. F. R., Samani, N. J., Roberts, R., & Paré, G. (2015) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.114.000952 · Cited by 90
Spiller, W., Slichter, D., Bowden, J., & Davey Smith, G. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy204 · Cited by 90
Peters, K. E., Beilby, J. P., Cadby, G., Warrington, N. M., Bruce, D. G., Davis, W. A., Davis, T. M. E., Wiltshire, S., Knuiman, M. W., McQuillan, B., et al. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-15 · Cited by 91
H-type hypertension and risk of stroke in chinese adults: A prospective, nested case–control study
Li, J., Jiang, S., Zhang, Y., Tang, G., Wang, Y., Mao, G., Li, Z., Xu, X., Wang, B., & Huo, Y. (2015) · Journal of Translational Internal Medicine · doi:10.1515/jtim-2015-0027 · Cited by 90
Identifying Novel Causes of Cancers to Enhance Cancer Prevention: New Strategies Are Needed
Brennan, P., & Smith, G. D. (2021) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djab204 · Cited by 92
Patel, A. R., Ye, T., Xue, H., Lin, Z., Xu, S., Woolf, B. A. R., Mason, A. M., & Burgess, S. (2023) · Wellcome Open Research · doi:10.12688/wellcomeopenres.19995.1 · Cited by 89
Wang, Q., Oliver-Williams, C., Raitakari, O. T., Viikari, J., Lehtimäki, T., Kähönen, M., Järvelin, M.-R., Salomaa, V., Perola, M., Danesh, J., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehaa972 · Cited by 89
Prenatal Nutrition, Epigenetics and Schizophrenia Risk: Can We Test Causal Effects?
Kirkbride, J. B., Susser, E., Kundaković, M., Kresovich, J. K., Smith, G. D., & Relton, C. L. (2012) · Epigenomics · doi:10.2217/epi.12.20 · Cited by 93
The development of personality across the lifespan
Donnellan, M. B., & Robins, R. W. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511596544.015 · Cited by 89
Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study
Dixon‐Suen, S. C., Nagle, C. M., Thrift, A. P., Pharoah, P. D. P., Pearce, C. L., Zheng, W., Painter, J. N., AOCS Group & Australian Cancer Study (Ovarian Cancer), Chenevix‐Trench, G., Fasching, P. A., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw158 · Cited by 93
Hannon, E. J., Weedon, M., Bray, N. J., O’Donovan, M. C., & Mill, J. S. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.04.013 · Cited by 90
Joint analysis of SNP and gene expression data in genetic association studies of complex diseases
Huang, Y.-T., VanderWeele, T. J., & Lin, X. (2014) · The Annals of Applied Statistics · doi:10.1214/13-aoas690 · Cited by 88
Burgess, S., & Thompson, S. G. (2012) · Statistics in Medicine · doi:10.1002/sim.4498 · Cited by 87
Walker, V. M., Kehoe, P. G., Martin, R. M., & Davies, N. M. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyz155 · Cited by 96
Heavier smoking increases coffee consumption: findings from a Mendelian randomization analysis
Bjørngaard, J. H., Nordestgaard, A. T., Taylor, A. E., Treur, J. L., Gabrielsen, M. E., Munafo, M. R., Nordestgaard, B. G., Åsvold, B. O., Romundstad, P., & Smith, G. D. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx147 · Cited by 96
MR-Clust: clustering of genetic variants in Mendelian randomization with similar causal estimates
Foley, C. N., Mason, A. M., Kirk, P., & Burgess, S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa778 · Cited by 81
Causal inference for heritable phenotypic risk factors using heterogeneous genetic instruments
Wang, J., Zhao, Q., Bowden, J., Hemani, G., Smith, G. D., Small, D. S., & Zhang, N. R. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009575 · Cited by 85
Using human genetics to improve safety assessment of therapeutics
Carss, K., Deaton, A. M., Río-Espínola, A. D., Diogo, D., Fielden, M. R., Kulkarni, D. A., Moggs, J. G., Newham, P., Nelson, M. R., Sistare, F. D., et al. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00561-w · Cited by 90
JOINT ANALYSIS OF SNP AND GENE EXPRESSION DATA IN GENETIC ASSOCIATION STUDIES OF COMPLEX DISEASES1Preprint
Huang, Y., Tyler, J., V, & Lin, X. (2013) · Cited by 88
Doepker, C., Lieberman, H. R., Smith, A. P., Peck, J. D., El-Sohemy, A., & Welsh, B. T. (2016) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-041715-033243 · Cited by 87
When Will Mendelian Randomization Become Relevant for Clinical Practice and Public Health?
Davey Smith, G., Paternoster, L., & Relton, C. (2017) · JAMA · doi:10.1001/jama.2016.21189 · Cited by 87
Burgess, S., Zuber, V., Gkatzionis, A., Rees, J. M., & Foley, C. N. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy080 · Cited by 88
Johansson, M., Carreras‐Torres, R., Scélo, G., Purdue, M. P., Mariosa, D., Muller, D. C., Timpson, N. J., Haycock, P., Brown, K. M., Wang, Z., et al. (2019) · PLoS Medicine · doi:10.1371/journal.pmed.1002724 · Cited by 90
Guo, Z., Kang, H., Cai, T., & Small, D. S. (2018) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/rssb.12275 · Cited by 87
Hübel, C., Gaspar, H. A., Coleman, J. R. I., Hanscombe, K. B., Purves, K. L., Prokopenko, I., Graff, M., Ngwa, J. S., Workalemahu, T., O’Reilly, P. F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13544-0 · Cited by 86
Lung function and cardiovascular disease: a two-sample Mendelian randomisation study
Higbee, D., Granell, R., Sanderson, E. C. M., Smith, G. D., & Dodd, J. W. (2021) · European Respiratory Journal · doi:10.1183/13993003.03196-2020 · Cited by 86
Martin, S., Sorokin, E. P., Thomas, E. L., Sattar, N. A., Cule, M., Bell, J. D., & Yaghootkar, H. (2022) · Diabetes Care · doi:10.2337/dc21-1262 · Cited by 91
C-reactive protein and cardiovascular disease: Weighing the evidence
Lowe, G. D. O., & Pepys, M. B. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0040-x · Cited by 87
Palmer, T., Thompson, J. R., Tobin, M. D., Sheehan, N. A., & Burton, P. R. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn080 · Cited by 87
Genetic evidence that carbohydrate-stimulated insulin secretion leads to obesity
Astley, C. M., Todd, J. N., Salem, R. M., Vedantam, S., Ebbeling, C. B., Huang, P. L., Ludwig, D. S., Hirschhorn, J. N., & Florez, J. C. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.280727 · Cited by 86
Temperament and brain networks of attention
Posner, M. I., & Rothbart, M. K. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0254 · Cited by 95
Homocysteine and small vessel stroke: A mendelian randomization analysis
Larsson, S. C., Traylor, M., & Markus, H. S. (2019) · Annals of Neurology · doi:10.1002/ana.25440 · Cited by 85
Respiratory Disease and Lower Pulmonary Function as Risk Factors for Dementia
Russ, T. C., Mika Kivimaki, B., & Batty, G. D. (2020) · CHEST Journal · doi:10.1016/j.chest.2019.12.012 · Cited by 89
Zhang, J., Chen, Z., Pärna, K., van Zon, S. K. R., Snieder, H., & Thio, C. H. L. (2022) · Diabetologia · doi:10.1007/s00125-022-05705-6 · Cited by 90
Berstein, F. M., McCartney, D. L., Lu, A. T., Tsilidis, K. K., Bouras, E., Haycock, P., Burrows, K., Phipps, A. I., Buchanan, D. D., Cheng, I. C., et al. (2022) · eLife · doi:10.7554/elife.75374 · Cited by 89
Rahmioglu, N., Macgregor, S., Drong, A. W., Hedman, A. K., Harris, H. R., Randall, J. C., Prokopenko, I., The International Endogene Consortium (IEC), T. G. C., Nyholt, D. R., Morris, A. P., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu516 · Cited by 85
Yang, Q., Sanderson, E., Tilling, K., Borges, M. C., & Lawlor, D. A. (2019) · doi:10.1101/19009605 · Cited by 85
Hemani, G., Bowden, J., Haycock, P., Zheng, J., Davis, O., Flach, P., Gaunt, T., & Smith, G. D. (2017) · doi:10.1101/173682 · Cited by 85
The CHRNA5–A3–B4 Gene Cluster and Smoking: From Discovery to Therapeutics
Lassi, G., Taylor, A. E., Timpson, N. J., Kenny, P. J., Mather, R. J., Eisen, T., & Munafò, M. R. (2016) · Trends in Neurosciences · doi:10.1016/j.tins.2016.10.005 · Cited by 85
Is epidemiology ready for epigenetics?
Relton, C. L., & Smith, G. D. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys006 · Cited by 87
Richardson, T. G., Hemani, G., Gaunt, T. R., Relton, C. L., & Smith, G. D. (2020) · Nature Communications · doi:10.1038/s41467-019-13921-9 · Cited by 84
Intraocular Pressure, Glaucoma, and Dietary Caffeine Consumption
Kim, J., Aschard, H., Kang, J. H., Lentjes, M. A. H., Do, R., Wiggs, J. L., Khawaja, A. P., & Pasquale, L. R. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2020.12.009 · Cited by 85
Bentley, P., Peck, G., Smeeth, L. L., Whittaker, J. C., & Sharma, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009136 · Cited by 86
Meta-analysis of genetic studies using Mendelian randomization—a multivariate approach
Thompson, J. R., Minelli, C., Abrams, K. R., Tobin, M. D., & Riley, R. D. (2005) · Statistics in Medicine · doi:10.1002/sim.2100 · Cited by 85
Metadata
- Authors
- Davey Smith, G., & Ebrahim, S.
- ORCID
- Ebrahim, Shah
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-02
- Volume
- 32
- Issue
- 1
- Pages
- 1-22
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2106036991
- Cited by
- 5,882
- References
- 179
- Citations by year
- 2026: 333 · 2025: 673 · 2024: 1162 · 2023: 681 · 2022: 453 · 2021: 442 · 2020: 353 · 2019: 235 · 2018: 201 · 2017: 157 · 2016: 163 · 2015: 118 · 2014: 115 · 2013: 94 · 2012: 101
- FWCI
- 31.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Physical Performance
- Keywords
- Mendelian randomization, genetic epidemiology, environmental factors in disease, causal inference, confounding, reverse causality, linkage disequilibrium, canalization, genetic polymorphism, genetic testing, public health genetics, disease prevention, Human Genome Project, pathogenesis, cancer genetics
- MeSH terms
- Animals, Disease, Environmental Exposure, Genotype, Humans, Polymorphism, Genetic, Molecular Epidemiology, Risk Assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
